<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-42960" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Streptococcus Pyogenes</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kanwal</surname>
            <given-names>Sidrah</given-names>
          </name>
          <aff>Allama Iqbal Medical College, Lahore, Pakistan</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Vaitla</surname>
            <given-names>Pradeep</given-names>
          </name>
          <aff>University of Mississippi Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sidrah Kanwal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Pradeep Vaitla declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>31</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-42960.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Streptococcus pyogenes is a major human-specific bacterial pathogen that causes a wide array of manifestations ranging from mild localized infections to life-threatening invasive infections. Ineffective treatment of S. pyogenes infections can result in the postinfectious sequela acute rheumatic fever and post-streptococcal glomerulonephritis. Moreover, it causes invasive infections like necrotizing fasciitis and toxic shock syndrome that is associated with and high morbidity and mortality. This activity describes the bacterium Streptococcus pyogenes (S. pyogenes) and reviewed the epidemiology, clinical manifestations of S. pyogenes infections, evaluation, and management of clinical infections caused by S. pyogenes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of S. pyogenes.</p></list-item><list-item><p>Outline the appropriate history, physical, and evaluation of Streptococcal pharyngitis.</p></list-item><list-item><p>Review the management options available for Streptococcal pharyngitis.</p></list-item><list-item><p>Describe the interprofessional team strategies for improving care coordination and communication to improve the outcome of severe invasive infections caused by S. pyogenes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=42960&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=42960">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-42960.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p><italic toggle="yes">Streptococcus pyogenes</italic> is a major human-specific bacterial pathogen that causes a wide array of manifestations ranging from mild localized infections to life-threatening invasive infections.<xref ref-type="bibr" rid="article-42960.r1">[1]</xref>&#x000a0;Ineffective treatment of&#x000a0;<italic toggle="yes">S. pyogenes</italic>&#x000a0;infections can result in the postinfectious sequela acute rheumatic fever and post-streptococcal glomerulonephritis.&#x000a0;Moreover, it&#x000a0;causes invasive infections like necrotizing fasciitis and toxic shock syndrome that is associated with and high morbidity and mortality.</p>
        <p>Streptococci are gram-positive, catalase-negative, coagulase-negative cocci that occur in pairs or chains. They are divided into three groups by the type of hemolysis on blood agar: beta-hemolytic (complete lysis of red cells), a hemolytic (green hemolysis), and gamma-hemolytic (no hemolysis).&#x000a0;Beta-hemolytic streptococci are characterized as group A streptococci (<italic toggle="yes">Streptococcus pyogenes</italic>) and group B streptococci (<italic toggle="yes">Streptococcus agalactiae</italic>).</p>
      </sec>
      <sec id="article-42960.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p><italic toggle="yes">S. pyogenes</italic>&#x000a0;is a gram-positive, catalase-negative, oxidase negative, &#x003b2;-hemolytic&#x000a0;streptococci. It is a facultative anaerobe, grows best in 5&#x000a0;to 10% carbon dioxide, and forms pinpoint colonies on blood agar plates.&#x000a0;Lancefield serological grouping system is used to differentiate group A streptococci (GAS) from other streptococci. The type A antigen of <italic toggle="yes">S. pyogenes</italic> is a polysaccharide which comprised of&#x000a0;N-acetylglucosamine attached to a rhamnose polymer backbone.<xref ref-type="bibr" rid="article-42960.r2">[2]</xref>&#x000a0;M protein is the major surface protein presents on <italic toggle="yes">S. pyogenes</italic>&#x000a0;cell wall, and GAS strains are further divided into different serotypes based on the antigenic characteristics of the M protein.&#x000a0;More than 80 different serotypes have been identified on the basis of M protein.<xref ref-type="bibr" rid="article-42960.r2">[2]</xref>.&#x000a0;&#x000a0;Depending upon the postinfectious sequelae, <italic toggle="yes">S. pyogenes</italic> are categorized into two classes: Class I and Class II. Class I strains cause rheumatic fever while class II strains result in acute glomerulonephritis.<xref ref-type="bibr" rid="article-42960.r3">[3]</xref></p>
        <p><italic toggle="yes">S. pyogenes</italic> usually colonizes, pharynx, anus, and genital mucosa. Infections caused by <italic toggle="yes">S. pyogenes</italic> are highly contagious. Transmission can occur through airborne droplets, hand contact with nasal discharge or with objects or surfaces contaminated with bacteria, skin contact with contaminated lesions, or contaminated food sources. GAS Strains may acquire access to the skin via abrasions and skin lesions and may lead to erysipelas or cellulitis.<xref ref-type="bibr" rid="article-42960.r2">[2]</xref>&#x000a0;GAS can cause&#x000a0;infection in muscle and fascia resulting in myositis and necrotizing fascitis usually following a mild trauma and can result in toxic shock syndrome. <italic toggle="yes">S. pyogenes</italic> can cause the infection of the vaginal mucosa and uterus causing septicemia.<xref ref-type="bibr" rid="article-42960.r2">[2]</xref>&#x000a0;Skin lesions have been identified as the most common predisposing factor for severe <italic toggle="yes">S. pyogenes</italic> infections.<xref ref-type="bibr" rid="article-42960.r4">[4]</xref>&#x000a0;Crowded settings like military camps, nursing houses, and schools cause ease of transmission of the organism and result in epidemics of group A streptococci infection.</p>
      </sec>
      <sec id="article-42960.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The frequency of the infections caused by <italic toggle="yes">S. pyogenes</italic> varies in different parts of the world, depending upon clinical manifestations of the infections. GAS has always been associated with serious diseases that result in high morbidity and mortality. GAS infections declined by the mid of the 20th century. However, by the end of 1980,&#x000a0;severe group A streptococcus (GAS) infections remerged.<xref ref-type="bibr" rid="article-42960.r5">[5]</xref>&#x000a0;Over the last two decades, non-suppurative and suppurative complications of the <italic toggle="yes">S. pyogenes</italic> infection have increased. This increase in disease burden can be attributed to the multitude of factors including, change of virulence and resistance to antibiotics.<xref ref-type="bibr" rid="article-42960.r6">[6]</xref><xref ref-type="bibr" rid="article-42960.r7">[7]</xref>&#x000a0;GAS infections and its complications vary between poorly developed and well-developed countries. In under-developed countries, the prevalence of rheumatic heart disease (RHD) and the incidence of deaths associated with RHD are high. Conversely, in well-developed countries, the incidence of deaths due to invasive GAS infection is high.</p>
        <p>The global burden of severe <italic toggle="yes">S. pyogenes</italic> infections is&#x000a0;18.1 million cases, with 1.78 million new cases per year.&#x000a0; The worldwide prevalence of RHD is at least 15.6 million cases, with the incidence of 282,000 new cases per year. Approximately 233,000 deaths per year are attributed to RHD.&#x000a0;Each year approximately 663,000 new cases of invasive GAS disease have been reported with 163,000 deaths per year.<xref ref-type="bibr" rid="article-42960.r8">[8]</xref> 616 million cases of sore throat infection worldwide per year can be attributed to <italic toggle="yes">S. pyogenes</italic>; also, 111 million cases of skin infection in children of developing countries.&#x000a0;<xref ref-type="bibr" rid="article-42960.r1">[1]</xref>. In the United States, 15% to 30% of cases of pharyngitis in children and 5% to 20% pharyngitis cases per year in adults are due to S. pyogenes. Moreover, the resurgence of cases&#x000a0;of ARF in the children of middle c&#x000ad;lass families of the United States has been observed.<xref ref-type="bibr" rid="article-42960.r9">[9]</xref></p>
        <p>Throat infection is more common in temperate areas, and its incidence increases in late winter and early spring.&#x000a0;Impetigo is more prevalent in children of humid climates. It has also been observed that the severity of invasive skin infections caused by GAS escalated from January to April and correlates with the host susceptibility to acquiring a serious infection.<xref ref-type="bibr" rid="article-42960.r10">[10]</xref></p>
      </sec>
      <sec id="article-42960.s5" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p>Multiple virulence factors are responsible for clinical manifestations of the <italic toggle="yes">S. pyogenes</italic>. Bacterial capsule consisted of hyaluronic acid provides protection against phagocytosis. M protein, lipoteichoic acid, and protein F are responsible for the attachment of the bacteria to host cells. M protein is also responsible for inhibiting opsonization by binding to complement regulators and to fibrinogen.&#x000a0;M protein is the most important virulence factor for&#x000a0;<italic toggle="yes">S. pyogenes</italic>&#x000a0;since experiments have shown that M&#x000a0;mutants cannot survive in phagocyte-containing human blood.<xref ref-type="bibr" rid="article-42960.r11">[11]</xref>&#x000a0;<italic toggle="yes">S. pyogenes</italic> also produce exotoxins, like a pyrogenic (erythrogenic) toxin, which is responsible for the rash of&#x000a0;scarlet fever&#x000a0;and toxic shock syndrome. Other virulent factors include streptokinase,&#x000a0;streptodornase,&#x000a0;hyaluronidase, and&#x000a0;streptolysins, which help in the invasion of tissues.</p>
      </sec>
      <sec id="article-42960.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>History and physical findings will vary depending upon the type of infection acquired; nonetheless, an accurate history and proper clinical evaluation are required to reach an accurate clinical diagnosis of <italic toggle="yes">S. pyogenes</italic> infection.&#x000a0;</p>
        <p>Sore throat is usually a major complaint in the case of streptococcus pharyngitis. The most common clinical findings for&#x000a0;Streptococcal pharyngitis include sudden onset of fever, malaise,&#x000a0;pharyngeal exudate, tender cervical lymphadenopathy and, enlarged tonsils.<xref ref-type="bibr" rid="article-42960.r12">[12]</xref>&#x000a0;</p>
        <p>In children, impetigo is one of the most common skin infections. S. pyogenes cause non-bullous impetigo. Typically the itchy reddish rash appears around mouth or nose that becomes fluid-filled blister later on. Blisters&#x000a0;rupture easily and are covered with honey-colored crust. The lesions are usually well-localized and affect exposed areas of the body: face and lower extremities. There are typically no systemic manifestations of the impetigo.</p>
        <p>Patient with scarlet fever usually presents with high-grade fever, sore throat, strawberry-like tongue, and a blanchable, papular, non-confluent rash. The rash typically lasts for 7 to 10 weeks, follows by desquamation.&#x000a0;Desquamation can only be observed on the palms and soles.<xref ref-type="bibr" rid="article-42960.r13">[13]</xref></p>
        <p>Soft tissue invasive infections due to <italic toggle="yes">S. pyogenes</italic> mostly present with shock and multiorgan failure.</p>
        <p>Necrotizing fasciitis due to group A streptococcus (<italic toggle="yes">S. pyogenes</italic>) is a deep-seated infection of the subcutaneous tissue that causes rapid destruction of fascia and fat. Systemically or locally immunocompromised individuals are at increased risk for developing necrotizing fasciitis. Other risk factors include surgical procedures, burns, blunt trauma, minor laceration, and childbirth.&#x000a0;Localized pain, necrosis of the infected skin lesion, swelling, redness, edema, increased heart rate,&#x000a0;and fever are the typical manifestations of necrotizing fasciitis. In the advanced stage of the disease, a picture of septic shock can be present.<xref ref-type="bibr" rid="article-42960.r14">[14]</xref></p>
      </sec>
      <sec id="article-42960.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p><italic toggle="yes">Streptococcus pyogenes</italic>, also known as group A streptococcus (GAS) is a leading cause of pharyngitis in children and adolescents. Clinicians should use clinical and epidemiological findings to determine the likelihood of GAS pharyngitis.&#x000a0;Infectious Disease Society of American (IDSA) recommends that a rapid antigen detection test (RADT) should be used as the first-line measure to assist the clinicians in the diagnosis of GAS pharyngitis. It is recommended to obtain throat cultures in children with negative RADT results to prevent the development of complications.<xref ref-type="bibr" rid="article-42960.r15">[15]</xref>&#x000a0;A combined approach using validated clinical criteria such as modified Centor score or the FeverPAIN score along with RADT is an effective strategy to reduce the cost of unnecessary testing and unwarranted antibiotics.</p>
        <p>&#x000a0;The gold standard test for the detection of GAS is throat culture; however, it is not cost-effective and can delay the treatment.<xref ref-type="bibr" rid="article-42960.r16">[16]</xref>&#x000a0;The pyrrolidinyl arylamidase activity (PYR)&#x000a0; test is used to distinguish <italic toggle="yes">S. pyogenes</italic> from other beta-hemolytic streptococci and tests for the presence of the enzyme pyrrolidinyl aminopeptidase.&#x000a0;</p>
        <p>Anti-streptolysin O (ASO) and anti-DNase B (ADB) titers indicate the previous streptococcal infection and can be used for the diagnosis of post-streptococcal complications.</p>
      </sec>
      <sec id="article-42960.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The drug of choice for treatment of bacterial pharyngitis is oral penicillin for 10 days or&#x000a0;IM benzathine penicillin. This treatment is cost-effective and has a narrow spectrum of activity.&#x000a0;</p>
        <p>In patients with penicillin allergy, macrolides and first-generation cephalosporins can be used.<xref ref-type="bibr" rid="article-42960.r17">[17]</xref><xref ref-type="bibr" rid="article-42960.r18">[18]</xref>&#x000a0;However, some strains of <italic toggle="yes">S. pyogenes</italic> have developed resistance to macrolides and macrolides are used as third-line of treatment for Streptococcal throat infection.<xref ref-type="bibr" rid="article-42960.r19">[19]</xref></p>
        <p>Severe invasive&#x000a0;<italic toggle="yes">S. pyogenes</italic>&#x000a0;infections can be treated with vancomycin or clindamycin.<xref ref-type="bibr" rid="article-42960.r20">[20]</xref>&#x000a0;Intravenous antibiotic therapy and surgery for the removal of necrotic tissue are recommended in the case of soft tissue skin infection by <italic toggle="yes">S. pyogenes</italic>.&#x000a0;</p>
      </sec>
      <sec id="article-42960.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Streptococcal pharyngitis should be differentiated from throat infections due to parainfluenza virus, rhinovirus, coxsackievirus, adenovirus, etc),&#x000a0;Mycoplasma&#x000a0;species,&#x000a0;<italic toggle="yes">Corynebacterium diphtheria</italic>, and&#x000a0;Epstein-Barr virus.&#x000a0;</p>
        <p>Scarlet fever can be confused with measles and rubella. However, the absence of symptoms of upper respiratory tract infection and confluent rash in measles can help to differentiate these diseases.</p>
        <p>Impetigo by <italic toggle="yes">S. pyogenes</italic>&#x000a0;needs to be differentiated from impetigo infection by staphylococcus aureus. <italic toggle="yes">S. pyogenes</italic> cause non-bullous impetigo while <italic toggle="yes">S. aureus</italic> leads to bullous impetigo.&#x000a0;</p>
      </sec>
      <sec id="article-42960.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>According to a report of the World Health Organization (WHO) GAS is the ninth leading infectious etiology of human mortality. The majority of deaths are due&#x000a0;to invasive infections and RHD,&#x000a0;especially in third world countries.<xref ref-type="bibr" rid="article-42960.r8">[8]</xref>&#x000a0;Severe GAS infections are high in affluent countries ranging from 14% to 19%.<xref ref-type="bibr" rid="article-42960.r21">[21]</xref>&#x000a0;Streptococcal pharyngitis typically resolves in 7 to 10 days. However, poor compliance with treatment can result in post-infection complications.&#x000a0;</p>
      </sec>
      <sec id="article-42960.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of <italic toggle="yes">S. pyogenes</italic> infections can be divided into suppurative and non-suppurative complications.</p>
        <p>Suppurative complications include peritonsillar&#x000a0;abscess, peritonsillar&#x000a0;cellulitis, retropharyngeal abscess, otitis&#x000a0;media and sinusitis, uvulitis, cervical lymphadenitis, meningitis, and brain abscess, arthritis, endocarditis, osteomyelitis, and liver abscess.</p>
        <p>Non-suppurative complications are&#x000a0;rheumatic fever, post-streptococcal glomerulonephritis, PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections), Sydenham chorea, and other autoimmune movement disorders.<xref ref-type="bibr" rid="article-42960.r19">[19]</xref></p>
      </sec>
      <sec id="article-42960.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients must be counseled about the importance of completing the course of antibiotics. They should be advised to follow up with a health care provider and to maintain&#x000a0;personal hygiene. The act of handwashing can severely decrease the chance of acquiring skin infections due to <italic toggle="yes">S. pyogenes</italic>.</p>
      </sec>
      <sec id="article-42960.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Ineffective treatment of skin or pharyngeal infection with group A streptococcus leads to acute rheumatic fever. Prevention of recurrent episodes of ARF and the development of potential serious outcomes of rheumatic heart disease require secondarily prophylaxis of penicillin. Secondary prophylaxis is the most effective method of reducing the incidence of ARF and RHD. Nevertheless, primary prophylaxis is gaining popularity throughout the globe.&#x000a0;Primary prevention comprises of prompt treatment of streptococcal throat or skin infection via a single injection of benzathine penicillin or oral penicillin for 10 days after confirmation of&#x000a0;<italic toggle="yes">S. pyogenes</italic> infection. Not only does prompt antibiotic treatment reduce the burden of ARF, but it also reduces the incidence of suppurative complications like otitis media.&#x000a0;</p>
      </sec>
      <sec id="article-42960.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>While the general health care provider is almost always involved in the care of patients with streptococcal&#x000a0;infection, caring for patients with the severe streptococcal disease, it is important to consult with an interprofessional team of specialists that include a general surgeon, plastic surgeon, radiologist,&#x000a0;&#x000a0;infectious disease, and speciality trained nurses.</p>
        <p>Necrotizing fasciitis is a life-threatening condition, and due to the complexity of this disease, a team approach is required. Since&#x000a0;necrotizing fasciitis is a surgical emergency, it is required that the patient should be admitted to a surgical intensive care unit, where the medical staff is skilled in performing debridement and, if needed, reconstructive surgery. Emergent surgical consultation is required to explore and debride the necrotic tissue. In addition, surgical exploration identifies the aetiology and extent of necrosis. CT and MRI may be helpful to locate the primary foci of infection. Hemodynamic stability should be maintained.</p>
        <p>In patients with toxic shock syndrome, monitoring of cardiac output is important. Due to the high incidence of acute respiratory distress syndrome (55%) in patients with severe Streptoccoal soft tissue infection, intubation, and ventilatory support are needed. Greater than 50% of patients with severe soft tissue infections can develop acute renal failure; hence, dialysis may be needed.</p>
      </sec>
      <sec id="article-42960.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=42960&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=42960">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/streptococcus-pyogenes/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=42960">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/42960/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=42960">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-42960.s16">
        <fig id="article-42960.image.f1" position="float" orientation="portrait">
          <caption>
            <p><italic toggle="yes">Streptococcus Pyogenes </italic>Bacteria. This illustration depicts a photomicrograph of a specimen revealing numbers of chain-linked <italic toggle="yes">S pyogenes</italic> bacteria. Public Health Image Library, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://phil.cdc.gov/Details.aspx?pid=2109">Public Domain</ext-link>, via Centers for Disease Control and Prevention&#x000a0;</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="611px-Streptococcus_pyogenes_01" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-42960.s17">
        <title>References</title>
        <ref id="article-42960.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ibrahim</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Eisen</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Jospin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Coil</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Khazen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tokajian</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Genome Analysis of Streptococcus pyogenes Associated with Pharyngitis and Skin Infections.</article-title>
            <source>PLoS One</source>
            <year>2016</year>
            <volume>11</volume>
            <issue>12</issue>
            <fpage>e0168177</fpage>
            <pub-id pub-id-type="pmid">27977735</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42960.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cunningham</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis of group A streptococcal infections.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2000</year>
            <month>Jul</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>470</fpage>
            <page-range>470-511</page-range>
            <pub-id pub-id-type="pmid">10885988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42960.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferretti</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>McShan</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Ajdic</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Savic</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Savic</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lyon</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Primeaux</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sezate</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Suvorov</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Kenton</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Qian</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Jia</surname>
                <given-names>HG</given-names>
              </name>
              <name>
                <surname>Najar</surname>
                <given-names>FZ</given-names>
              </name>
              <name>
                <surname>Ren</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yuan</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Clifton</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Roe</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>McLaughlin</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Complete genome sequence of an M1 strain of Streptococcus pyogenes.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2001</year>
            <month>Apr</month>
            <day>10</day>
            <volume>98</volume>
            <issue>8</issue>
            <fpage>4658</fpage>
            <page-range>4658-63</page-range>
            <pub-id pub-id-type="pmid">11296296</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42960.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lamagni</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Darenberg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Luca-Harari</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Siljander</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Efstratiou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Henriques-Normark</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Vuopio-Varkila</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bouvet</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Creti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ekelund</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Koliou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Reinert</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Stathi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Strakova</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ungureanu</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Schal&#x000e9;n</surname>
                <given-names>C</given-names>
              </name>
              <collab>Strep-EURO Study Group</collab>
              <name>
                <surname>Jasir</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of severe Streptococcus pyogenes disease in Europe.</article-title>
            <source>J Clin Microbiol</source>
            <year>2008</year>
            <month>Jul</month>
            <volume>46</volume>
            <issue>7</issue>
            <fpage>2359</fpage>
            <page-range>2359-67</page-range>
            <pub-id pub-id-type="pmid">18463210</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42960.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stevens</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Invasive group A streptococcus infections.</article-title>
            <source>Clin Infect Dis</source>
            <year>1992</year>
            <month>Jan</month>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>2</fpage>
            <page-range>2-11</page-range>
            <pub-id pub-id-type="pmid">1571429</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42960.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martin</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Barbadora</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Wald</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh.</article-title>
            <source>N Engl J Med</source>
            <year>2002</year>
            <month>Apr</month>
            <day>18</day>
            <volume>346</volume>
            <issue>16</issue>
            <fpage>1200</fpage>
            <page-range>1200-6</page-range>
            <pub-id pub-id-type="pmid">11961148</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42960.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quinn</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fischetti</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Hemric</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cunningham</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>Immunological relationship between the class I epitope of streptococcal M protein and myosin.</article-title>
            <source>Infect Immun</source>
            <year>1998</year>
            <month>Sep</month>
            <volume>66</volume>
            <issue>9</issue>
            <fpage>4418</fpage>
            <page-range>4418-24</page-range>
            <pub-id pub-id-type="pmid">9712796</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42960.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carapetis</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Steer</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Mulholland</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The global burden of group A streptococcal diseases.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>5</volume>
            <issue>11</issue>
            <fpage>685</fpage>
            <page-range>685-94</page-range>
            <pub-id pub-id-type="pmid">16253886</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42960.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Veasy</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Wiedmeier</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Orsmond</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Ruttenberg</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Boucek</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Roth</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Tait</surname>
                <given-names>VF</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Daly</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>Resurgence of acute rheumatic fever in the intermountain area of the United States.</article-title>
            <source>N Engl J Med</source>
            <year>1987</year>
            <month>Feb</month>
            <day>19</day>
            <volume>316</volume>
            <issue>8</issue>
            <fpage>421</fpage>
            <page-range>421-7</page-range>
            <pub-id pub-id-type="pmid">3807984</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42960.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Olafsdottir</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Erlendsd&#x000f3;ttir</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Melo-Cristino</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Weinberger</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Ramirez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kristinsson</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Gottfredsson</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Invasive infections due to Streptococcus pyogenes: seasonal variation of severity and clinical characteristics, Iceland, 1975 to 2012.</article-title>
            <source>Euro Surveill</source>
            <year>2014</year>
            <month>May</month>
            <day>01</day>
            <volume>19</volume>
            <issue>17</issue>
            <fpage>5</fpage>
            <page-range>5-14</page-range>
            <pub-id pub-id-type="pmid">24821122</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42960.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MAXTED</surname>
                <given-names>WR</given-names>
              </name>
            </person-group>
            <article-title>The indirect bactericidal test as a means of identifying antibody to the M antigen of Streptococcus pyogenes.</article-title>
            <source>Br J Exp Pathol</source>
            <year>1956</year>
            <month>Aug</month>
            <volume>37</volume>
            <issue>4</issue>
            <fpage>415</fpage>
            <page-range>415-22</page-range>
            <pub-id pub-id-type="pmid">13364152</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42960.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ebell</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Barry</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Ives</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Carey</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The rational clinical examination. Does this patient have strep throat?</article-title>
            <source>JAMA</source>
            <year>2000</year>
            <month>Dec</month>
            <day>13</day>
            <volume>284</volume>
            <issue>22</issue>
            <fpage>2912</fpage>
            <page-range>2912-8</page-range>
            <pub-id pub-id-type="pmid">11147989</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42960.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Basetti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hodgson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rawson</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Majeed</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Scarlet fever: a guide for general practitioners.</article-title>
            <source>London J Prim Care (Abingdon)</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>9</volume>
            <issue>5</issue>
            <fpage>77</fpage>
            <page-range>77-79</page-range>
            <pub-id pub-id-type="pmid">29081840</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42960.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Misiakos</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Bagias</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Patapis</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sotiropoulos</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kanavidis</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Machairas</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Current concepts in the management of necrotizing fasciitis.</article-title>
            <source>Front Surg</source>
            <year>2014</year>
            <volume>1</volume>
            <fpage>36</fpage>
            <pub-id pub-id-type="pmid">25593960</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42960.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stewart</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Clemans-Taylor</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Littenberg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Estrada</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Centor</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Rapid antigen group A streptococcus test to diagnose pharyngitis: a systematic review and meta-analysis.</article-title>
            <source>PLoS One</source>
            <year>2014</year>
            <volume>9</volume>
            <issue>11</issue>
            <fpage>e111727</fpage>
            <pub-id pub-id-type="pmid">25369170</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42960.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fox</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Marcon</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Bonsu</surname>
                <given-names>BK</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis of streptococcal pharyngitis by detection of Streptococcus pyogenes in posterior pharyngeal versus oral cavity specimens.</article-title>
            <source>J Clin Microbiol</source>
            <year>2006</year>
            <month>Jul</month>
            <volume>44</volume>
            <issue>7</issue>
            <fpage>2593</fpage>
            <page-range>2593-4</page-range>
            <pub-id pub-id-type="pmid">16825390</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42960.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choby</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and treatment of streptococcal pharyngitis.</article-title>
            <source>Am Fam Physician</source>
            <year>2009</year>
            <month>Mar</month>
            <day>01</day>
            <volume>79</volume>
            <issue>5</issue>
            <fpage>383</fpage>
            <page-range>383-90</page-range>
            <pub-id pub-id-type="pmid">19275067</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42960.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Optimal Diagnosis and Treatment of Group A Streptococcal Pharyngitis.</article-title>
            <source>Infect Chemother</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>47</volume>
            <issue>3</issue>
            <fpage>202</fpage>
            <page-range>202-4</page-range>
            <pub-id pub-id-type="pmid">26483997</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42960.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Hamad</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Streptococcal throat. Therapeutic options and macrolide resistance.</article-title>
            <source>Saudi Med J</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>36</volume>
            <issue>9</issue>
            <fpage>1128</fpage>
            <page-range>1128-9</page-range>
            <pub-id pub-id-type="pmid">26318475</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42960.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ikebe</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hirasawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Isobe</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Katsukawa</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kawahara</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tomita</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ogata</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Endoh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Okuno</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>49</volume>
            <issue>2</issue>
            <fpage>788</fpage>
            <page-range>788-90</page-range>
            <pub-id pub-id-type="pmid">15673769</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42960.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lepoutre</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Doloy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bidet</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Leblond</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Perrocheau</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bingen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Trieu-Cuot</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bouvet</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Poyart</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>L&#x000e9;vy-Bruhl</surname>
                <given-names>D</given-names>
              </name>
              <collab>Microbiologists of the Epibac Network</collab>
            </person-group>
            <article-title>Epidemiology of invasive Streptococcus pyogenes infections in France in 2007.</article-title>
            <source>J Clin Microbiol</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>49</volume>
            <issue>12</issue>
            <fpage>4094</fpage>
            <page-range>4094-100</page-range>
            <pub-id pub-id-type="pmid">21976764</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
